Catalyst Wire Dossier Catalyst Wire Dossier

GMZ2 malaria vaccine

GMZ2
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GMZ2 malaria vaccine, covering 2008-11-25 to 2008-11-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of 30 and 100 µg of GMZ2 in Gabonese Children Aged 1-5 Years [Phase 1]

See pricing